These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 33780371)

  • 1. Economic Burden of Alzheimer's Disease Dementia in Japan.
    Ikeda S; Mimura M; Ikeda M; Wada-Isoe K; Azuma M; Inoue S; Tomita K
    J Alzheimers Dis; 2021; 81(1):309-319. PubMed ID: 33780371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The estimated cost of dementia in Japan, the most aged society in the world.
    Sado M; Ninomiya A; Shikimoto R; Ikeda B; Baba T; Yoshimura K; Mimura M
    PLoS One; 2018; 13(11):e0206508. PubMed ID: 30418983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2021 Alzheimer's disease facts and figures.
    Alzheimers Dement; 2021 Mar; 17(3):327-406. PubMed ID: 33756057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification tree model of the personal economic burden of dementia care by related factors of both people with dementia and caregivers in Japan: a cross-sectional online survey.
    Nakabe T; Sasaki N; Uematsu H; Kunisawa S; Wimo A; Imanaka Y
    BMJ Open; 2019 Jul; 9(7):e026733. PubMed ID: 31289069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the Severity of Alzheimer's Disease on the Quality of Life, Activities of Daily Living, and Caregiving Costs for Institutionalized Patients on Anti-Alzheimer Medications in Japan.
    Ashizawa T; Igarashi A; Sakata Y; Azuma M; Fujimoto K; Kobayashi T; Takase Y; Ikeda S
    J Alzheimers Dis; 2021; 81(1):367-374. PubMed ID: 33780368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between global severity of patients with Alzheimer's disease and costs of care in Spain; results from the co-dependence study in Spain.
    Darbà J; Kaskens L; Lacey L
    Eur J Health Econ; 2015 Nov; 16(8):895-905. PubMed ID: 25348897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs and Resource Use Associated with Community-Dwelling Patients with Alzheimer's Disease in Japan: Baseline Results from the Prospective Observational GERAS-J Study.
    Nakanishi M; Igarashi A; Ueda K; Brnabic AJM; Treuer T; Sato M; Kahle-Wrobleski K; Meguro K; Yamada M; Mimura M; Arai H
    J Alzheimers Dis; 2020; 74(1):127-138. PubMed ID: 31985460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and longitudinal changes of informal cost of Alzheimer's disease in the community.
    Zhu CW; Scarmeas N; Torgan R; Albert M; Brandt J; Blacker D; Sano M; Stern Y
    J Am Geriatr Soc; 2006 Oct; 54(10):1596-602. PubMed ID: 17038080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive cost of illness of dementia in Japan: a time trend analysis based on Japanese official statistics.
    Hanaoka S; Matsumoto K; Kitazawa T; Fujita S; Seto K; Hasegawa T
    Int J Qual Health Care; 2019 Apr; 31(3):231-237. PubMed ID: 30272131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2013 Alzheimer's disease facts and figures.
    Alzheimer's Association
    Alzheimers Dement; 2013 Mar; 9(2):208-45. PubMed ID: 23507120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting the Societal Value of Lecanemab in Early Alzheimer's Disease in Japan: A Patient-Level Simulation.
    Igarashi A; Azuma MK; Zhang Q; Ye W; Sardesai A; Folse H; Chavan A; Tomita K; Tahami Monfared AA
    Neurol Ther; 2023 Aug; 12(4):1133-1157. PubMed ID: 37188886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs and Resource Use Associated with Alzheimer's Disease in Italy: Results from an Observational Study.
    Bruno G; Mancini M; Bruti G; Dell'Agnello G; Reed C
    J Prev Alzheimers Dis; 2018; 5(1):55-64. PubMed ID: 29405234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2024 Alzheimer's disease facts and figures.
    Alzheimers Dement; 2024 May; 20(5):3708-3821. PubMed ID: 38689398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Family and Caregiver Spillover Effects in Cost-Utility Analyses of Alzheimer's Disease Interventions.
    Lin PJ; D'Cruz B; Leech AA; Neumann PJ; Sanon Aigbogun M; Oberdhan D; Lavelle TA
    Pharmacoeconomics; 2019 Apr; 37(4):597-608. PubMed ID: 30903567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Projected Costs of Informal Caregiving for Cardiovascular Disease: 2015 to 2035: A Policy Statement From the American Heart Association.
    Dunbar SB; Khavjou OA; Bakas T; Hunt G; Kirch RA; Leib AR; Morrison RS; Poehler DC; Roger VL; Whitsel LP;
    Circulation; 2018 May; 137(19):e558-e577. PubMed ID: 29632217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of school-based family asthma educational programs on the quality of life and number of asthma exacerbations of children aged five to 18 years diagnosed with asthma: a systematic review protocol.
    Walter H; Sadeque-Iqbal F; Ulysse R; Castillo D; Fitzpatrick A; Singleton J
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):69-81. PubMed ID: 26571284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major Cost Drivers in Assessing the Economic Burden of Alzheimer's Disease: A Structured, Rapid Review.
    Kosaner Kließ M; Martins R; Connolly MP
    J Prev Alzheimers Dis; 2021; 8(3):362-370. PubMed ID: 34101795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2016 Alzheimer's disease facts and figures.
    Alzheimer's Association
    Alzheimers Dement; 2016 Apr; 12(4):459-509. PubMed ID: 27570871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burden in caregivers of patients with schizophrenia, depression, dementia, and stroke in Japan: comparative analysis of quality of life, work productivity, and qualitative caregiving burden.
    Kojima Y; Yamada S; Kamijima K; Kogushi K; Ikeda S
    BMC Psychiatry; 2024 Sep; 24(1):591. PubMed ID: 39223532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with long-term impact on informal caregivers during Alzheimer's disease dementia progression: 36-month results from GERAS.
    Reed C; Belger M; Scott Andrews J; Tockhorn-Heidenreich A; Jones RW; Wimo A; Dodel R; Haro JM
    Int Psychogeriatr; 2020 Feb; 32(2):267-277. PubMed ID: 31134870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.